NEW ENGLAND ZENITH FUND
485APOS, EX-99.H11, 2000-12-21
Previous: NEW ENGLAND ZENITH FUND, 485APOS, EX-99.H10, 2000-12-21
Next: NEW ENGLAND ZENITH FUND, 485APOS, EX-99.M1, 2000-12-21



<PAGE>

                                                                 Exhibit (h)(11)

                            PARTICIPATION AGREEMENT
                                     Among
                           NEW ENGLAND ZENITH FUND,
                   NEW ENGLAND INVESTMENT MANAGEMENT, INC.,
                      NEW ENGLAND SECURITIES CORPORATION
                                      and
                    GENERAL AMERICAN LIFE INSURANCE COMPANY

         AGREEMENT, made and entered into as of the 1st day of May, 2000 by and
among NEW ENGLAND ZENITH FUND, a business trust organized under the laws of the
Commonwealth of Massachusetts (the "Fund"), General American Life Insurance
Company (the "Company") on its own behalf and on behalf of Separate Account
Eleven and any other current or future separate account which invests in the
Fund (each an "Account"), each a separate account of the Company, NEW ENGLAND
INVESTMENT MANAGEMENT, INC. (the "Adviser") and NEW ENGLAND SECURITIES
CORPORATION (the "Underwriter").

         WHEREAS, the Fund is registered as an open-end management investment
company under the Investment Company Act of 1940, as amended (the "1940 Act")
and its shares are registered under the Securities Act of 1933, as amended
(hereinafter the "1933 Act"); and

         WHEREAS, the Fund serves as an investment vehicle underlying variable
life insurance policies and variable annuity contracts (collectively, "Variable
Insurance Products") offered by insurance companies ("Participating Insurance
Companies"); and

         WHEREAS, the beneficial interest in the Fund is divided into several
series of shares, each representing the interest in a particular managed
portfolio of securities and other assets; and

         WHEREAS, the Fund has obtained an order from the Securities and
Exchange Commission ("SEC") granting Participating Insurance Companies and
variable annuity and variable life insurance separate accounts exemptions from
certain provisions of the 1940 Act and certain rules and regulations thereunder,
to the extent necessary to permit shares of the Fund to be sold to and held by
both variable annuity and variable life insurance separate accounts of both
affiliated and unaffiliated life insurance companies (hereinafter the "Shared
Funding Exemptive Order"); and

         WHEREAS, the Adviser acts as the investment adviser and/or
administrator or subadministrator to each series of the Fund and is registered
as an investment adviser under the Investment Advisers Act of 1940, as amended;
and

         WHEREAS, the Company has registered or will register certain variable
life and/or variable annuity contracts under the 1933 Act, if required;

         WHEREAS, the Company has registered or will register each Account as a
unit investment trust under the 1940 Act, if required;

                                       1
<PAGE>

         WHEREAS, the Underwriter is registered as a broker dealer with the SEC
under the Securities Exchange Act of 1934, as amended (the "1934 Act"), and is a
member in good standing of the National Association of Securities Dealers, Inc.
(the "NASD"); and

         WHEREAS, to the extent permitted by applicable insurance laws and
regulations, the Company intends to purchase shares of certain series of the
Fund (the "Series") on behalf of each Account to fund certain variable life and
variable annuity contracts (each, a "Contract") and the Underwriter is
authorized to sell such shares to each Account at net asset value;

         NOW, THEREFORE, in consideration of their mutual promises, the Company,
the Fund and the Underwriter agree as follows:

1.       Sale of Fund Shares.
         -------------------

1.1      Subject to the terms of the Distribution Agreement in effect from time
         to time between the Fund and the Underwriter, the Underwriter agrees to
         sell to the Company those shares of each Series which each Account
         orders, executing such orders on a daily basis at the net asset value
         next computed after receipt by the Fund or its designee of the order
         for the shares of the Fund. For purposes of this Section 1.1 and
         Section 1.4, the Company is the Fund's designee. "Business Day" shall
         mean any day on which the New York Stock Exchange is open for trading
         and on which the Fund calculates the net asset value of shares of the
         Series. The Company shall use commercially reasonable efforts to
         communicate notice of orders for the purchase of Shares of each Series
         to the Fund's custodian by 10:00 a.m. Eastern time on the following
         Business Day (the "Next Business Day"), and the Company and the Fund
         shall each use commercially reasonable efforts to wire (or cause to be
         wired) funds to the other, for the purpose of settling net purchase
         orders or orders of redemption, by 3:00 p.m. of the Next Business Day.

1.2      The Fund agrees to make its shares available for purchase at the
         applicable net asset value per share by the Company and its Accounts on
         those days on which the Fund calculates its net asset value. The Fund
         agrees to use reasonable efforts to calculate such net asset value on
         each day which the New York Stock Exchange is open for trading.
         Notwithstanding the foregoing, the Board of Trustees of the Fund
         (hereinafter the "Board" or the "Trustees") may refuse to sell shares
         of any Series to any person, or suspend or terminate the offering of
         shares of any Series, if such action is required by law or by
         regulatory authorities having jurisdiction or is, in the sole
         discretion of the Trustees acting in good faith and in light of their
         fiduciary duties under federal and any applicable state laws, in the
         best interests of the shareholders of such Series.

1.3      The Fund and the Underwriter agree that shares of the Fund will be sold
         only to Participating Insurance Companies and their separate accounts,
         or to other purchasers of the kind specified in Treas. Reg. Section
         1.817-5 (f)(3) (or any successor regulation) as from time to time in
         effect.

1.4      The Fund agrees to redeem, on the Company's request, any full or
         fractional shares of the Fund held by the Company, executing such
         requests on a daily basis at the net asset value

                                       2
<PAGE>

         next computed after receipt by the Fund or its designee of the request
         for redemption. The Company shall use commercially reasonable efforts
         to communicate notice of orders for the redemption of Shares of each
         Series to the Fund's custodian by 10:00 a.m. Eastern time on the Next
         Business Day, and the Company and the Fund shall each use commercially
         reasonable efforts to wire (or cause to be wired) funds to the other,
         for the purpose of settling net purchase orders or orders of
         redemption, by 3:00 p.m. of the Next Business Day.

1.5      The Company agrees that all purchases and redemptions by it of the
         shares of each Series will be in accordance with the provisions of the
         then current prospectus and statement of additional information of the
         Fund for the respective Series and in accordance with any procedures
         that the Fund, the Underwriter or the Fund's transfer agent may have
         established governing purchases and redemptions of shares of the Series
         generally.

1.6      The Company shall pay for Fund shares on the next Business Day after an
         order to purchase Fund shares is made in accordance with the provisions
         of Section 1.1. hereof. Payment shall be in federal funds transmitted
         by wire to the Fund's custodian.

1.7      Issuance and transfer of the Funds' shares will be by book entry only.
         Share certificates will not be issued. Shares ordered from the Fund
         will be recorded on the transfer records of the Fund in an appropriate
         title for each Account or the appropriate subaccount of each Account.

1.8      The Fund shall furnish same day notice (by e-mail, fax or telephone,
         followed by written confirmation) to the Company of any income,
         dividends or capital gain distributions payable on the shares of any
         Series. The Company hereby elects to receive all such income dividends
         and capital gain distributions as are payable on the Series shares in
         additional shares of that Series. The Company reserves the right to
         revoke this election and to receive all such income dividends and
         capital gain distributions in cash. The Fund shall notify the Company
         of the number of shares so issued as payment of such dividends and
         distributions.

1.9      The Fund shall make the net asset value per share for each Series
         available to the Company on a daily basis as soon as reasonably
         practical after the net asset value per share is calculated and shall
         use its best efforts to make such net asset value per share available
         by 7:00 p.m. Eastern time. The Fund shall furnish the Company's daily
         share balance to the Company as soon as reasonably practicable.

2.       Representations and Warranties.
         ------------------------------

2.1      The Company represents and warrants that each Contract shall be either
         (i) registered, or prior to the purchase of shares of any Series in
         connection with the funding of such Contract, will be registered under
         the 1933 Act or (ii) exempt from such registration; that the Contracts
         will be issued and sold in compliance in all material respects with all
         applicable federal and state laws, including all applicable customer
         suitability requirements. The Company further represents and warrants
         that it is an insurance

                                       3
<PAGE>

         company duly organized and in good standing under applicable law and
         that it has legally and validly established each Account as a separate
         account pursuant to relevant state insurance law prior to any issuance
         or sale of any Contract by such Account and that each Account shall be
         either (i) registered or, prior to any issuance or sale of the
         Contracts, will register each Account as a unit investment trust in
         accordance with the provisions of the 1940 Act; or (ii) exempt from
         such registration.

2.2      The Fund represents and warrants that Fund shares sold pursuant to this
         Agreement shall be registered under the 1933 Act, duly authorized for
         issuance and sold in compliance with the laws of the Commonwealth of
         Massachusetts and all applicable federal and state securities laws and
         that the Fund is and shall remain registered under the 1940 Act. The
         Fund agrees that it will amend the registration statement for its
         shares under the 1933 Act and the 1940 Act from time to time as
         required in order to permit the continuous public offering of its
         shares in accordance with the 1933 Act. The Fund shall register and
         qualify the shares for sale in accordance with the laws of the various
         states only if and to the extent deemed advisable by the Fund or the
         Underwriter.

2.3      The Fund represents that each Series is currently qualified as a
         "regulated investment company" under subchapter M of the Internal
         Revenue Code of 1986, as amended, (the "Code") and agrees that it will
         make every effort to maintain such qualification (under Subchapter M or
         any successor or similar provision) and that it will notify the Company
         promptly upon having a reasonable basis for believing that it has
         ceased to so qualify or that it might not so qualify in the future.

2.4      Subject to Section 6.1, the Company represents that the Contracts are
         currently treated as endowment, annuity or life insurance contracts
         under applicable provisions of the Code and agrees that it will make
         every effort to maintain such treatment and that it will notify the
         Fund and the Underwriter immediately upon having a reasonable basis for
         believing that the Contracts have ceased to be so treated or that they
         might not be so treated in the future.

2.5      The Fund makes no representation as to whether any aspect of its
         operations (including, but not limited to, fees and expenses and
         investment policies) complies with the insurance laws or regulations of
         the various states.

2.6      The Underwriter represents and warrants that it is a member in good
         standing of the NASD and is registered as a broker-dealer with the SEC.

2.7      The Underwriter further represents that it will sell and distribute the
         Fund shares in accordance with all applicable state and federal
         securities laws, including without limitation the 1933 Act, the 1934
         Act and the 1940 Act.

2.8      The Fund represents that it is lawfully organized and validly existing
         under the laws of the Commonwealth of Massachusetts and that it does
         and will comply in all material respects with the 1940 Act.

                                       4
<PAGE>

2.9      Each of the Fund, the Adviser and the Underwriter represent and warrant
         that all of their directors, officers and employees dealing with the
         money and/or securities of the Fund are and shall continue to be at all
         times covered by a blanket fidelity bond or similar coverage in an
         amount, in the case of the Adviser and the Underwriter, of not less
         than $5,000,000 and, in the case of the Fund, not less than the minimal
         coverage as required by Rule 17g-1 under the 1940 Act or any successor
         regulations as may be promulgated from time to time. Each aforesaid
         bond shall include coverage for larceny and embezzlement of Fund assets
         and shall be issued by a reputable bonding company.

2.10     The Company represents and warrants that all of its directors,
         officers, employees and other individuals/entities dealing with the
         money and/or securities representing amounts intended for the purchase
         of shares of the Fund or proceeds of the redemption of shares of the
         Fund are and shall continue to be at all times covered by a blanket
         fidelity bond or similar coverage in an amount not less than
         $5,000,000. The aforesaid Bond shall include coverage for larceny and
         embezzlement of Fund assets and shall be issued by a reputable bonding
         company.

2.11     The Company represents and warrants that it will not, without the prior
         written consent of the Fund and the Adviser, purchase Fund shares with
         Account assets derived from the sale of Contracts to individuals or
         entities which would cause the investment policies of any Series to be
         subject to any limitations not in the Fund's then current prospectus or
         statement of additional information with respect to any Series.

3.       Prospectuses and Proxy Statements; Voting.
         -----------------------------------------

3.1      The Underwriter (or the Fund) shall provide the Company with as many
         copies of the Fund's current prospectus as the Company may reasonably
         request (at the Company's expense with respect to other than existing
         Contract owners). If requested by the Company in lieu thereof, the
         Underwriter (or the Fund) shall provide such documentation (including a
         final copy of the new prospectus as set in type at the Fund's expense)
         and other assistance as is reasonably necessary in order for the
         Company once each year (or more frequently if the prospectus for the
         Fund is amended) to have the prospectus for the Contracts and the
         Fund's prospectus printed together in one document (such printing to be
         at the Company's expense with respect to other than existing Contract
         owners).

3.2      The Underwriter (or the Fund), at its expense, shall print and provide
         the Fund's then current statement of additional information free of
         charge to the Company and to any owner of a Contract or prospective
         owner who requests such statement.

3.3      The Fund, at its expense, shall provide the Company with copies of its
         proxy material, reports to shareholders and other communications to
         shareholders in such quantity as the Company shall reasonably require
         for distribution (at the Fund's expense) to Contract owners.

3.4      So long as and to the extent that the SEC or its staff continues to
         interpret the 1940 Act to require pass-through voting privileges for
         variable contract owners, or if and to the extent

                                       5
<PAGE>

         required by law, the Company shall: (i) solicit voting instructions
         from Contract owners; (ii) vote the Fund shares in accordance with
         instructions received from Contract owners; and (iii) vote Fund shares
         for which no instructions have been received in the same proportion as
         Fund shares of such Series for which instructions have been received.
         The Company reserves the right to vote Fund shares held in any Account
         in its own right, to the extent permitted by law. The Company shall be
         responsible for assuring that each Account participating in the Fund
         calculates voting privileges in a manner consistent with the standards
         set forth on Schedule A hereto, which standards will also be provided
         to the other Participating Insurance Companies.

4.       Sales Material and Information.
         ------------------------------

4.1      The Company shall be solely responsible for sales literature or other
         promotional material, in which the Fund, a Series, the Adviser, any
         subadviser to any Series, or the Underwriter (in its capacity as
         distributor of the Fund) is named, the substance of which is contained
         in the then current prospectus or statement of additional information
         of the Fund. Other sales literature or other promotional material may
         also be used by the Company if such sales literature or other
         promotional material (or the substance thereof) has been previously
         approved by the Fund or its designee. All other sales literature or
         other promotional material shall not be used by the Company until it
         has been approved by the Fund or its designee. The Company shall
         deliver such draft sales literature or other promotional material to
         the Fund or its designee at least thirty Business days prior to its
         use. The Fund or such designee shall use commercially reasonable
         efforts to review sales literature so delivered within ten days.

4.2      The Company shall not give any information or make any representations
         or statements on behalf of the Fund or concerning the Fund in
         connection with the sale of the Contracts other than the information or
         representations contained in the registration statement, prospectus or
         statement of additional information for the Fund shares, as such
         registration statement and prospectus or statement of additional
         information may be amended or supplemented from time to time, or in
         reports or proxy statements for the Fund, or in sales literature or
         other promotional material approved by the Fund or its designee or by
         the Underwriter, except with the approval of the Fund or the
         Underwriter or the designee of either.

4.3      The obligations set forth in Section 4.1 herein shall apply mutatis
                                                                     -------
         mutandis to the Fund and the Underwriter with respect to each piece of
         --------
         sales literature or other promotional material in which the Company
         and/or any Account is named.

4.4      The Fund and the Underwriter shall not give any information or make any
         representations on behalf of the Company or concerning the Company, any
         Account or the Contracts other than the information or representations
         contained in a registration statement or prospectus for the Contracts,
         as such registration statement and prospectus may be amended or
         supplemented from time to time, or in published reports for each
         Account which are in the public domain or approved by the Company for
         distribution to Contract

                                       6
<PAGE>

         owners, or in sales literature or other promotional material approved
         by the Company or its designee, except with the permission of the
         Company.

4.5      The Fund will provide to the Company at least one complete copy of all
         registration statements, prospectuses, statements of additional
         information, shareholder annual, semi-annual or other reports, proxy
         statements, applications for exemptions, requests for no-action letters
         and any amendments to any of the above, that relate to any Series,
         promptly after the filing of each such document with the SEC or any
         other regulatory authority.

4.6      The Company will provide to the Fund at least one complete copy of all
         registration statements, prospectuses, statements of additional
         information, shareholder annual, semi-annual or other reports,
         solicitations for voting instructions, applications for exemptions,
         requests for no-action letters and any amendments to any of the above,
         that relate to the Contracts or any Account, promptly after the filing
         of such document with the SEC or any other regulatory authority. Each
         party hereto will provide to each other party, to the extent it is
         relevant to the Contracts or the Fund, a copy of any comment letter
         received from the staff of the SEC or the NASD, and the Company's
         response thereto, following any examination or inspection by the staff
         of the SEC or the NASD.

4.7      As used herein, the phrase "sales literature or other promotional
         material" includes, but is not limited to, advertisements (such as
         material published, or designed for use in, a newspaper, magazine, or
         other periodical, radio, television, telephone or tape recording,
         videotape display, signs or billboards, motion pictures or other public
         media), sales literature (i.e., any written communication distributed
         or made generally available to customers or the public, including
         brochures, circulars, research reports, market letters, form letters,
         seminar texts, reprints or excerpts of any other advertisement, sales
         literature or published article), educational or training materials or
         other communications distributed or made generally available to some or
         all agents or employees.

5.       Fees and Expenses.
         -----------------

5.1      The Fund, the Adviser and the Underwriter shall pay no fee or other
         compensation to the Company under this agreement, except that if the
         Fund or any Series adopts and implements a plan pursuant to Rule 12b-1
         to finance distribution expenses, then the Fund may make payments to
         the Underwriter or to the Company. Each party acknowledges that the
         Adviser may pay service or administrative fees to the Company and other
         Participating Insurance Companies pursuant to separate agreements.

6.       Diversification.
         ---------------

6.1      The Fund will at all times invest money from the Contracts in such a
         manner as to ensure that the Contracts will be treated as variable
         contracts under the Code and the regulations issued thereunder. Without
         limiting the scope of the foregoing, the Fund will at all times comply
         with Section 817(h) of the Code and any Treasury Regulations thereunder

                                       7
<PAGE>

         relating to the diversification requirements for variable annuity,
         endowment or life insurance contracts, as from time to time in effect.




7.       Potential Conflicts.
         -------------------

7.1      To the extent required by the Shared Funding Exemptive Order or by
         applicable law, the Board of Trustees of the Fund (the "Board") will
         monitor the Fund for the existence of any material irreconcilable
         conflict between the interests of the contract owners of all separate
         accounts investing in the Fund. An irreconcilable material conflict may
         arise for a variety of reasons, including: (a) an action by any state
         insurance regulatory authority; (b) a change in applicable federal or
         state insurance, tax, or securities laws or regulations, or a public
         ruling, private letter ruling, no-action or interpretative letter, or
         any similar action by insurance, tax, or securities regulatory
         authorities; (c) an administrative or judicial decision in any relevant
         proceeding; (d) the manner in which the investments of any Series are
         being managed; (e) a difference in voting instructions given by
         variable annuity contract and variable life insurance contract owners;
         or (f) a decision by an insurer to disregard the voting instructions of
         contract owners. The Fund shall promptly inform the Company if it
         determines that an irreconcilable material conflict exists and the
         implications thereof.

7.2      The Company will report to the Board any potential or existing
         conflicts between the interests of contract owners of different
         separate accounts of which the Company is or becomes aware. The Company
         will assist the Board in carrying out its responsibilities under the
         Shared Funding Exemptive Order and under applicable law, by providing
         the Board with all information reasonably necessary for the Board to
         consider any issues raised. This includes, but is not limited to, an
         obligation of the Company to inform the Board whenever contract owner
         voting instructions are disregarded.

7.3      If it is determined by a majority of the Board, or a majority of its
         disinterested trustees, that a material irreconcilable conflict exists,
         the Company and other Participating Insurance Companies shall, at their
         expense take whatever steps are necessary to remedy or eliminate the
         irreconcilable material conflict, which steps could include: (1)
         withdrawing the assets allocable to some or all of the separate
         accounts from the Fund or any Series and reinvesting such assets in a
         different investment medium, including (but not limited to) another
         series of the Fund, or submitting the question of whether such
         segregation should be implemented to a vote of all affected Contract
         owners and, as appropriate, segregating the assets of any appropriate
         group (i.e., annuity contract owners, life insurance contract owners,
         or variable contract owners of one or more Participating Insurance
         Companies) that votes in favor of such segregation, or offering to the
         affected contract owners the option of making such a change; and (2)
         establishing a new registered management investment company or managed
         separate account.

                                       8
<PAGE>

7.4      If a material irreconcilable conflict arises because of a decision by
         the Company to disregard Contract owner voting instructions and that
         decision represents a minority position or would preclude a majority
         vote, the Company may be required, at the Fund's election, to withdraw
         the relevant Account's investment in the Fund and terminate this
         Agreement; provided, however, that such withdrawal and termination
         shall be limited to the extent required by such material irreconcilable
         conflict as determined by a majority of the disinterested members of
         the Board. Any such withdrawal and termination will take place within
         six (6) months after the Fund gives written notice that this provision
         is being implemented.

7.5      If a material irreconcilable conflict arises because a particular state
         insurance regulator's decision applicable to the Company conflicts with
         the majority of other state regulators, then the Company will withdraw
         the affected Account's investment in the Fund and terminate this
         Agreement within six months after the Board informs the Company in
         writing that it has determined that such decision has created an
         irreconcilable material conflict; provided, however, that such
         withdrawal and termination shall be limited to the extent required by
         such material irreconcilable conflict as determined by a majority of
         the disinterested members of the Board.

7.6      For purposes of Sections 7.3 through 7.6 of this Agreement, a majority
         of the disinterested members of the Board shall determine whether any
         proposed action adequately remedies any irreconcilable material
         conflict, but in no event will the Fund be required to establish a new
         funding medium for the Contracts. The Company shall not be required by
         Section 7.3 to establish a new funding medium for the Contracts if an
         offer to do so has been declined by vote of a majority of Contract
         owners materially adversely affected by the irreconcilable material
         conflict. In the event that the Board determines that any proposed
         action does not adequately remedy any irreconcilable material conflict,
         then the Company will withdraw the Account's investment in the Fund and
         terminate this Agreement within six (6) months after the Board informs
         the Company in writing of the foregoing determination, provided,
         however, that such withdrawal and termination shall be limited to the
         extent required by any such material irreconcilable conflict as
         determined by a majority of the disinterested members of the Board.

7.7      If and to the extent that Rule 6e-2 and Rule 6e-3(T) under the 1940 Act
         are amended, or Rule 6e-3 is adopted, to provide exemptive relief from
         any provision of the Act or the rules promulgated thereunder with
         respect to mixed or shared funding (as defined in the Shared Funding
         Exemptive Order) on terms and conditions materially different from
         those contained in the Shared Funding Exemptive Order, then (a) the
         Fund and/or Participating Insurance Companies, as appropriate, shall
         take such steps as may be necessary to comply with Rules 6e-2 and 6e-
         3(T), as amended, and Rule 6e-3, as adopted, to the extent such rules
         are applicable; and (b) Sections 3.4, 7.1, 7.2, 7.3, 7.4, and 7.5 of
         this Agreement shall continue in effect only to the extent that terms
         and conditions substantially identical to such Sections are contained
         in such Rule(s) as so amended or adopted.

                                       9
<PAGE>

8.       Indemnification.
         ---------------

8.1      Indemnification by the Company

         (a) The Company agrees to indemnify and hold harmless the Fund and each
         of its Trustees and officers and each person, if any, who controls the
         Fund within the meaning of Section 15 of the 1933 Act (collectively,
         the "Indemnified Parties" for purposes of this Section 8.1) against any
         and all losses, claims, damages, liabilities (including amounts paid in
         settlement with the written consent of the Company) or litigation
         (including legal and other expenses), to which the Indemnified Parties
         may become subject under any statute, regulation, at common law or
         otherwise, insofar as such losses, claims, damages, liabilities or
         expenses (or actions in respect thereof) or settlements are related to
         the sale or acquisition of the Fund's shares or the Contracts and: (i)
         arise out of or are based upon any untrue statements or alleged untrue
         statements of any material fact contained in the registration statement
         or prospectus or statement of additional information (if applicable)
         for the Contracts or contained in the Contracts or sales literature or
         other promotional material for the Contracts (or any amendment or
         supplement to any of the foregoing), or arise out of or are based upon
         the omission or the alleged omission to state therein a material fact
         required to be stated therein or necessary to make the statements
         therein not misleading, provided that this agreement to indemnify shall
         not apply as to any Indemnified Party if such statement or omission or
         such alleged statement or omission was made in reliance upon and in
         conformity with information furnished to the Company by or on behalf of
         the Fund for use in the registration statement or prospectus or
         statement of additional information (if applicable) for the Contracts
         or in the Contracts or sales literature or other promotional material
         (or any amendment or supplement) or otherwise for use in connection
         with the sale of the Contracts or Fund shares; or (ii) arise out of or
         as a result of statements or representations (other than statements or
         representations contained in the registration statement, prospectus or
         statement of additional information (if applicable) or sales literature
         or other promotional material of the Fund not supplied by the Company,
         or persons under its control) or wrongful conduct of the Company or
         persons under its control, with respect to the sale or distribution of
         the Contracts or Fund Shares; or (iii) arise out of any untrue
         statement or alleged untrue statement of a material fact contained in
         any registration statement, prospectus or statement of additional
         information (if applicable) or sales literature or other promotional
         material of the Fund or any amendment thereof or supplement thereto or
         the omission or alleged omission to state therein a material fact
         required to be stated therein or necessary to make the statements
         therein not misleading if such a statement or omission was made in
         reliance upon information furnished to the Fund by or on behalf of the
         Company; or (iv) arise as a result of any failure by the Company to
         provide the services and furnish the materials under the terms of this
         Agreement; or (v) arise out of or result from any material breach of
         any representation and/or warranty made by the Company in this
         Agreement or arise out of or result from any other material breach of
         this Agreement by the Company, as limited by and in accordance with the
         provisions of Section 8.1(b) and 8.1(c) hereof.

                                       10
<PAGE>

         (b) The Company shall not be liable under this Section 8.1 with respect
         to any losses, claims, damages, liabilities or litigation to which an
         Indemnified Party would otherwise be subject if such loss, claim,
         damage, liability or litigation is caused by or arises out of such
         Indemnified Party's willful misfeasance, bad faith or gross negligence
         or by reason of such Indemnified Party's reckless disregard of
         obligations or duties under this Agreement or to the Fund, whichever is
         applicable.

         (c) Each Indemnified Party shall notify the Company of any claim made
         against an Indemnified Party in writing within a reasonable time after
         the summons or other first legal process giving information of the
         nature of the claim shall have been served upon such Indemnified Party
         (or after such Indemnified Party shall have received notice of such
         service on any designated agent), but failure to notify the Company of
         any such claim shall not relieve the Company from any liability which
         it may have to the Indemnified Party against whom such action is
         brought under this indemnification provision unless the Company's
         ability to defend against the claim shall have been materially
         prejudiced by the Indemnified Party's failure to give such notice and
         shall not in any way relieve the Company from any liability which it
         may have to the Indemnified Party against whom the action is brought
         otherwise than on account of this indemnification provision. In case
         any such action is brought against one or more Indemnified Parties, the
         Company shall be entitled to participate, at its own expense, in the
         defense of such action. The Company also shall be entitled to assume
         the defense thereof, with counsel satisfactory to each Indemnified
         Party named in the action. After notice from the Company to such party
         of the Company's election to assume the defense thereof, the
         Indemnified Party shall bear the fees and expenses of any additional
         counsel retained by it, and the Company will not be liable to such
         party under this Agreement for any legal or other expenses subsequently
         incurred by such party independently in connection with the defense
         thereof other than reasonable costs of investigation. An Indemnified
         Party shall not settle any claim involving a remedy other than monetary
         damages without the prior written consent of the Company.

         (d) The Indemnified Parties will promptly notify the Company of the
         commencement of any litigation or proceedings against them in
         connection with the issuance or sale of the Fund Shares or the
         Contracts or the operation of the Fund.

8.2      Indemnification by the Adviser and the Underwriter

         (a) The Adviser and the Underwriter agree to indemnify and hold
         harmless the Company and each of its directors and officers and each
         person, if any, who controls the Company within the meaning of Section
         15 of the 1933 Act (collectively, the "Indemnified Parties" for
         purposes of this Section 8.2) against any and all losses, claims,
         damages, liabilities (including amounts paid in settlement with the
         written consent of the Adviser and the Underwriter) or litigation
         (including legal and other expenses) to which the Indemnified Parties
         may become subject under any statute, regulation, at common law or
         otherwise, insofar as such losses, claims, damages, liabilities or
         expenses (or actions in respect thereof) or settlements are related to
         the sale or acquisition of the Fund's shares or the Contracts and: (i)
         arise out of or are based upon any untrue statement or alleged untrue

                                       11
<PAGE>

         statement of any material fact contained in the registration statement,
         prospectus or statement of additional information, or sales literature
         or other promotional material of the Fund (or any amendment or
         supplement to any of the foregoing), or arise out of or are based upon
         the omission or the alleged omission to state therein a material fact
         required to be stated therein or necessary to make the statements
         therein not misleading, provided that this agreement to indemnify shall
         not apply as to any Indemnified Party if such statement or omission or
         such alleged statement or omission was made in reliance upon and in
         conformity with information furnished to the Adviser, the Underwriter,
         or Fund by or on behalf of the Company for use in the registration
         statement, prospectus or statement of additional information for the
         Fund or in sales literature or other promotional material (or any
         amendment or supplement) or otherwise for use in connection with the
         sale of the Contracts or Fund shares; or (ii) arise out of or as a
         result of statements or representations (other than statements or
         representations contained in the registration statement, prospectus or
         statement of additional information or sales literature or other
         promotional material for the Contracts not supplied by the Adviser, the
         Underwriter or the Fund or persons under their control) or wrongful
         conduct of the Adviser, the Underwriter or the Fund or persons under
         their control, with respect to the sale or distribution of the
         Contracts or Fund Shares; or (iii) arise out of any untrue statement or
         alleged untrue statement of a material fact contained in any
         registration statement, prospectus or statement of additional
         information or sales literature or other promotional material covering
         the Contracts, or any amendment thereof or supplement thereto, or the
         omission or alleged omission to state therein a material fact required
         to be stated therein or necessary to make the statements therein not
         misleading, if such statement or omission was made in reliance upon
         information furnished to the Company by or on behalf of the Adviser,
         the Underwriter, or the Fund; or (iv) arise as a result of any failure
         by the Adviser, the Underwriter or the Fund to provide the services and
         furnish the materials under the terms of this Agreement (including a
         failure, whether unintentional or in good faith or otherwise, to comply
         with the diversification requirements specified in Article VI of this
         Agreement); or (v) arise out of or result from any material breach of
         any representation and/or warranty made by the Adviser, the
         Underwriter, or the Fund in this Agreement or arise out of or result
         from any other material breach of this Agreement by the Adviser, the
         Underwriter, or the Fund; as limited by and in accordance with the
         provisions of Sections 8.2(b) and 8.2(c) hereof.

         (b) Neither the Adviser nor the Underwriter shall be liable under this
         Section 8.2 with respect to any losses, claims, damages, liabilities or
         litigation to which an Indemnified Party would otherwise be subject if
         such loss, claim, damage, liability or litigation is caused by or
         arises out of such Indemnified Party's willful misfeasance, bad faith
         or gross negligence or by reason of such Indemnified Party's reckless
         disregard of obligations and duties under this Agreement or to the
         Company or each Account, whichever is applicable.

         (c) Each Indemnified Party shall notify each of the Adviser, the
         Underwriter, and the Fund of any claim made against the Indemnified
         Party within a reasonable time after the summons or other first legal
         process giving information of the nature of the claim shall have been
         served upon such Indemnified Party (or after such Indemnified Party
         shall have received notice of such service on any designated agent),
         but failure to notify each of the

                                       12
<PAGE>

         Adviser, the Underwriter, and the Fund of any such claim shall not
         relieve the Adviser or the Underwriter from any liability which it may
         have to the Indemnified Party against whom such action is brought under
         this indemnification provision unless the Adviser or the Underwriter's
         ability to defend against the claim shall have been materially
         prejudiced by the Indemnified Party's failure to give such notice and
         shall not in any way relieve the Adviser or the Underwriter from any
         liability which it may have to the Indemnified Party against whom the
         action is brought otherwise than on account of this indemnification
         provision. In case any such action is brought against one or more
         Indemnified Parties, the Adviser and the Underwriter will be entitled
         to participate, at their own expense, in the defense thereof. The
         Adviser and/or the Underwriter shall be entitled to assume the defense
         thereof, with counsel satisfactory to the party named in the action.
         After notice from the Adviser and/or the Underwriter to such party of
         the election of the Adviser and/or the Underwriter to assume the
         defense thereof, the Indemnified Party shall bear the fees and expenses
         of any additional counsel retained by it, and the Adviser and/or the
         Underwriter will not be liable to such party under this Agreement for
         any legal or other expenses subsequently incurred by such party
         independently in connection with the defense thereof other than
         reasonable costs of investigation. An Indemnified Party shall not
         settle any claim involving any remedy other than monetary damages
         without the prior written consent of the Adviser and/or the
         Underwriter.

         (d) The Company agrees promptly to notify the Adviser, the Underwriter
         and the Fund of the commencement of any litigation or proceedings
         against it or any of its officers or directors in connection with the
         issuance or sale of the Contracts or the operation of each Account.

9.       Applicable Law.
         --------------

9.1      This Agreement shall be construed and the provisions hereof interpreted
         under and in accordance with the laws of the Commonwealth of
         Massachusetts.

9.2      This Agreement shall be subject to the provisions of the 1933, 1934 and
         1940 acts, and the rules and regulations and rulings thereunder,
         including such exemptions from those statutes, rules and regulations as
         the SEC may grant (including, but not limited to, the Shared Funding
         Exemptive Order) and the terms hereof shall be interpreted and
         construed in accordance therewith.

10.      Termination.
         -----------

10.1     This Agreement shall terminate:

         (a) at the option of any party upon 180 days' advance written notice to
         the other parties; provided, however, that such notice shall not be
         given earlier than one year following the date of this Agreement; or

         (b) at the option of the Company to the extent that shares of a Series
         are not reasonably available to meet the requirements of the Contracts
         as determined by the Company,

                                       13
<PAGE>

         provided however, that such termination shall apply only to those
         Series the shares of which are not reasonably available. Prompt notice
         of the election to terminate for such cause shall be furnished by the
         Company; or

         (c) at the option of the Fund in the event that formal administrative
         proceedings are instituted against the Company by the NASD, the SEC,
         any state insurance department or commissioner or similar insurance
         regulator or any other regulatory body regarding the Company's duties
         under this Agreement or related to the sale of the Contracts, with
         respect to the operation of any Account or the purchase by any Account
         of Fund shares, provided, however, that the Fund determines in its sole
         judgment, exercised in good faith, that any such administrative
         proceedings will have a material adverse effect upon the ability of the
         Company to perform its obligations under this Agreement; or

         (d) at the option of the Company in the event that formal
         administrative proceedings are instituted against the Fund, the Adviser
         or the Underwriter by the NASD, the SEC or any state securities or
         insurance department or commissioner or any other regulatory body,
         provided, however, that the Company determines in its sole judgment
         exercised in good faith, that any such administrative proceedings will
         have a material adverse effect upon the ability of the Fund, the
         Adviser or the Underwriter to perform its obligations under this
         Agreement; or

         (e) with respect to any Account, upon requisite authority (by vote of
         the Contract owners having an interest in such Account or any
         subaccount thereof, or otherwise) to substitute the shares of another
         investment company (or separate series thereof) for the shares of any
         Series in accordance with the terms of the Contracts for which shares
         of that Series had been selected to serve as the underlying investment
         medium. The Company will give 90 days' prior written notice to the Fund
         of the date of any proposed vote to replace the Fund's shares or of the
         filing by the Company with the SEC of any application relating to any
         such substitution; or

         (f) at the option of the Company, in the event any shares of any Series
         are not registered, issued or sold in accordance with applicable state
         and/or federal law or such law precludes the use of such shares as the
         underlying investment medium of the Contracts issued or to be issued by
         the Company; or

         (g) at the option of the Company, if any Series ceases to qualify as a
         Regulated Investment Company under Subchapter M of the Code or under
         any successor or similar provision, or if the Company reasonably
         believes that any Series may fail to so qualify; or

         (h) at the option of the Company, if the Fund fails to meet the
         diversification requirements specified in Section 6 hereof; or

         (i) at the option of the Fund, the Adviser or the Underwriter, if (1)
         the Fund, the Adviser or the Underwriter, as the case may be, shall
         determine, in its sole judgment reasonably exercised in good faith,
         that the Company has suffered a material adverse change in its business
         or financial condition or is the subject of material adverse publicity
         and such

                                       14
<PAGE>

         material adverse change or material adverse publicity will have a
         material adverse impact on the business and operations of the Fund, the
         Adviser or the Underwriter, as the case may be, (2) the Fund, the
         Adviser or the Underwriter shall notify the Company in writing of such
         determination and its intent to terminate this Agreement, and (3) after
         considering the actions taken by the Company and any other changes in
         circumstances since the giving of such notice, such determination of
         the Fund, the Adviser or the Underwriter shall continue to apply on the
         sixtieth (60th) day following the giving of such notice, which sixtieth
         day shall be the effective date of termination; or

         (j) at the option of the Company, if (1) the Company shall determine,
         in its sole judgment reasonably exercised in good faith, that the Fund,
         the Adviser or the Underwriter has suffered a material adverse change
         in its business or financial condition or is the subject of material
         adverse publicity and such material adverse change or material adverse
         publicity will have a material adverse impact upon the business and
         operations of the Company, (2) the Company shall notify the Fund, the
         Adviser and the Underwriter in writing of such determination and its
         intent to terminate the Agreement, and (3) after considering the
         actions taken by the Fund, the Adviser and/or the Underwriter and any
         other changes in circumstances since the giving of such notice, such
         determination shall continue to apply on the sixtieth (60th) day
         following the giving of such notice, which sixtieth day shall be the
         effective date of termination; or

         (k) in the case of an Account not registered under the 1933 Act or 1940
         Act, the Company shall give the Fund 90 days' prior written notice if
         the Company chooses to cease using any Series as an investment vehicle
         for such Account.

It is understood and agreed that the right of any party hereto to terminate this
Agreement pursuant to Section 10.1(a) may be exercised for any reason or for no
reason.

10.2     Notice Requirement. No termination of this Agreement shall be effective
         unless and until the party terminating this Agreement gives prior
         written notice to all other parties to this Agreement of its intent to
         terminate which notice shall set forth the basis for such termination.
         Furthermore, in the event that any termination is based upon the
         provisions of Article VII, or the provision of Section 10.1(a), 10.1(i)
         or 10.1(j) of this Agreement, such prior written notice shall be given
         in advance of the effective date of termination as required by such
         provisions; and

10.3     In the event that any termination is based upon the provisions of
         Section 10.1(c) or 10.1(d) of this Agreement, such prior written notice
         shall be given at least ninety (90) days before the effective date of
         termination.

10.4     Effect of Termination. Notwithstanding any termination of this
         Agreement, the Fund and the Underwriter shall, at the option of the
         Company, continue to make available additional shares of each Series
         pursuant to the terms and conditions of this Agreement, for all
         Contracts in effect on the effective date of termination of this
         Agreement (hereinafter referred to as "Existing Contracts").
         Specifically, without limitation, the owners of the Existing Contracts
         shall be permitted to reallocate investments in the Fund,

                                       15
<PAGE>

         redeem investments in the Fund and/or invest in the Fund upon the
         making of additional purchase payments under the Existing Contracts.
         The parties agree that this Section 10.4 shall not apply to any
         terminations under Section 10.1(b) or Section 7, and in the case of
         terminations under Section 7 terminations, the effect of such
         terminations shall be governed by Section 7 of this Agreement.

11.      Notices.
         -------

Any notice shall be sufficiently given when sent by registered or certified mail
to the other party at the address of such party set forth below or at such other
address as such party may from time to time specify in writing to the other
party.

If to the Fund or to the Adviser:

                  501 Boylston Street
                  Boston, Massachusetts  02116
                  Attention: Thomas M. Lenz, Secretary

If to the Company:

                  General American Life Insurance Company
                  700 Market Street
                  St. Louis, Missouri 63101
                  Attention: Christopher A. Martin, Counsel


If to the Underwriter:

                  501 Boylston Street
                  Boston, Massachusetts  02116
                  Attention:  Mary M. Diggins, Secretary


12.      Miscellaneous.
         -------------

12.1     A copy of the Agreement and Declaration of Trust establishing New
         England Zenith Fund is on file with the Secretary of the Commonwealth
         of Massachusetts, and notice is hereby given that this Agreement is
         executed on behalf of the Fund by officers of the Fund as officers and
         not individually and that the obligations of or arising out of this
         Agreement are not binding upon any of the trustees, officers or
         shareholders of the Fund individually but are binding only upon the
         assets and property belonging to the Series.

12.2     Subject to the requirements of legal process and regulatory authority,
         each party hereto shall treat as confidential the names and addresses
         of the owners of the Contracts and all information reasonably
         identified as confidential in writing by any other party hereto and,
         except as permitted by this Agreement, shall not disclose, disseminate
         or utilize such

                                       16
<PAGE>

         names and addresses and other confidential information until such time
         as it may come into the public domain without the express written
         consent of the affected party.

12.3     The captions in this Agreement are included for convenience of
         reference only and in no way define or delineate any of the provisions
         hereof or otherwise affect their construction or effect.

12.4     This Agreement may be executed simultaneously in two or more
         counterparts, each of which taken together shall constitute one and the
         same instrument.

12.5     If any provision of this Agreement shall be held or made invalid by a
         court decision, statute, rule or otherwise, the remainder of the
         Agreement shall not be affected thereby.

12.6     Each party hereto shall cooperate with each other party and all
         appropriate governmental authorities (including without limitation the
         SEC, the NASD and state insurance regulators) and shall permit such
         authorities reasonable access to its books and records in connection
         with any investigation or inquiry relating to this Agreement or the
         transactions contemplated hereby.

12.7     The rights, remedies and obligations contained in this Agreement are
         cumulative and are in addition to any and all rights, remedies and
         obligations, at law or in equity, which the parties hereto are entitled
         to under state and federal laws.

                                       17
<PAGE>

         IN WITNESS WHEREOF, each of the parties hereto has caused this
Agreement to be executed in its name and on its behalf by its duly authorized
representative and its seal to be hereunder affixed hereto as of the date
specified below.



GENERAL AMERICAN LIFE INSURANCE COMPANY

By:      /s/ Bernard H. Wolzenski
    --------------------------------
         Name: Bernard H Wolzenski
         Title: Executive Vice President

Date: May 1, 2000

NEW ENGLAND ZENITH FUND

By:      /s/ Anne M. Goggin
    ----------------------------------------
         Name: Anne M. Goggin
         Title: Chairman and President

Date: May 1, 2000


NEW ENGLAND INVESTMENT MANAGEMENT, INC.

By:      /s/ Anne M. Goggin
    ----------------------------------------
         Name: Anne M. Goggin
         Title: Chairman and President

Date: May 1, 2000



NEW ENGLAND SECURITIES CORPORATION

By:      /s/ Mary M. Diggins
    ----------------------------------------
         Name: Mary M. Diggins
         Title: Secretary

Date: May 1, 2000

                                       18
<PAGE>

                            PARTICIPATION AGREEMENT
                                     Among
                           NEW ENGLAND ZENITH FUND,
                   NEW ENGLAND INVESTMENT MANAGEMENT, INC.,
                      NEW ENGLAND SECURITIES CORPORATION
                                      and
                    GENERAL AMERICAN LIFE INSURANCE COMPANY


                                  SCHEDULE A


With respect to each Account, all shares of each Series attributable to such
policies and contracts for which no owner instructions have been received by the
Company and all shares of the Series attributable to charges assessed by the
Company against such policies and contracts will be voted for, voted against, or
withheld from voting on any proposal in the same proportions as are the shares
for which owner instructions have been received by the Company with respect to
policies or contracts issued by such Account. To the extent the Company has so
agreed with respect to an Account not registered with the SEC under the 1940
Act, all shares of each Series held by the Account will be voted for, voted
against or withheld from voting on any proposal in the same proportions as are
the shares of such Series for which contract owners' voting instructions have
been received. If the Company has not so agreed, the shares of each Series
attributable to such unregistered Account will be voted for, voted against, or
withheld from voting on any proposal in the same proportions as are all other
shares for which the Company has received voting instructions.

                                       19


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission